Prakasam district aims to vaccinate 11,000 girls aged 14-15 with a single-dose HPV vaccine to guard against future cervical cancer. The initiative, launched across urban and primary health centers, coincides with International Women's Day celebrations. Officials urge eligible girls and their families to utilize this public health measure.
District Collector Raja Babu and District Medical and Health Officer Dr. T. Venkateswarlu inaugurated the program. The vaccination is intended to prevent cervical cancer, a significant health concern for women. Health officials stated that the vaccine offers up to 98% protection against cervical cancer, a leading cancer among women. Early vaccination is noted as more effective due to a better immune response. The vaccine may also help prevent certain throat cancers caused by HPV infection.

The program will meticulously track vaccination details in real-time using the 'U-WIN' app, ensuring effective monitoring. Health authorities have appealed to parents and guardians to ensure their daughters receive the vaccine. Beyond cervical cancer, medical experts suggest the HPV vaccine could also be effective in preventing other HPV-related cancers, including anal and throat cancers.
Read More: Christina Applegate Shares MS Pain Struggles After Memoir Release
While the immediate focus is on girls aged 14-15, health officials also advised women over 30 to undergo regular screenings for early detection of potential issues, emphasizing that prompt diagnosis significantly improves treatment outcomes. Warning signs such as abnormal bleeding after intercourse, irregular bleeding between periods, foul-smelling vaginal discharge, or post-menopausal bleeding were highlighted as reasons to seek medical attention.

The launch event was attended by District Immunisation Officer Dr. Kamalashree, doctors Henna Keerthana and Sundar Prasad, District Mass Media Officer Narasimha Rao, and Srinivasulu, alongside other health personnel.
Background and Broader Context
Globally, the human papillomavirus (HPV) is recognized for its link to various cancers, primarily cervical cancer in women. The World Health Organization (WHO) collects and updates immunization coverage estimates annually, with data reflecting administrative and official reporting through the WHO/UNICEF Joint Reporting Form on Immunization.
Read More: India Opposition MPs Seek Removal of Chief Election Commissioner Gyanesh Kumar

In France, vaccination against HPV is recommended from age 11 up to 14 years for both boys and girls. Healthcare providers, including doctors and midwives, can prescribe and administer the vaccine, with pharmacists and nurses authorized to do so for individuals over 16. Discussions around improving HPV vaccination coverage have explored ways to address potential geographic inequalities.
In India, the HPV vaccine, specifically targeting strains like HPV 16 and 18 responsible for a high percentage of cervical cancer cases, is part of a broader public health effort. A previous report indicated plans for a 90-day nationwide drive offering free HPV shots to 14-year-old girls, aiming to significantly reduce cervical cancer incidence and mortality over time. The effectiveness of the vaccine, such as Gardasil 4, is considered important even if slightly less potent than newer versions like Gardasil 9, for widespread public health impact.
Read More: New Test Finds Hidden Chemical Changes in Antibody Drugs in 2024